市場調查報告書
商品編碼
1069232

全球神經修復與再生市場展望(2021-2028)

Nerve Repair and Regeneration - Global Market Outlook (2021 - 2028)

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球神經修復和再生市場預計將從 2021 年的 68.7 億美元增長到 2028 年的 143.6 億美元,預測期內的複合年增長率為 11.1%。

本報告研究和分析全球神經修復和再生市場,並按市場趨勢、產品、應用、最終用戶、地區和主要公司概況提供市場分析。

目錄

第 1 章執行摘要

第2章前言

第三章市場趨勢分析

  • 簡介
  • 促進因素
  • 抑制器
  • 市場機會
  • 威脅
  • 產品分析
  • 使用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第四章波特五力分析

第 5 章全球神經修復和再生市場:按產品分類

  • 簡介
  • 神經刺激/調節裝置
    • 外置神經刺激器
    • 內神經刺激器
  • 生物材料
    • 神經保護器
    • 神經接頭
    • 神經包裹
    • 神經管

第 6 章全球神經修復和再生市場:按用途

  • 簡介
  • 直接神經修復/神經縫合
    • 修復神經周圍
    • 神經外膜修復
    • 群神經束脩復
  • 幹細胞療法
  • 神經刺激/神經調節手術
    • 外部神經刺激/神經調節手術
    • 內神經刺激/神經調節手術
  • 神經移植
    • 異體移植
    • 自體□□移植
    • 異種移植

第 7 章全球神經修復和再生市場:按最終用戶

  • 簡介
  • 醫院
  • 診所
  • 門診手術中心

第 8 章全球神經修復和再生市場:按地區劃分

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 意大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 新西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東/非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 卡塔爾
    • 南非
    • 其他中東/非洲

第 9 章主要發展

  • 合同/聯盟/合作/合資
  • 收購/合併
  • 推出新產品
  • 擴展
  • 其他重要策略

第 10 章公司簡介

  • Abbott Laboratories
  • Medtronic, Plc.
  • Synapse Biomedical, Inc.
  • Baxter International, Inc.
  • Boston Scientific Corporation
  • Aleva Neurotherapeutics
  • Neuropace, Inc.
  • Axogen, Inc.
  • Collagen Matrix, Inc.
  • Integra Lifesciences
  • Livanova, Plc.
  • Kerimedical
  • Soterix Medical, Inc.
  • Nevro Corp.
  • Polyganics
目錄
Product Code: SMRC19219

According to Stratistics MRC, the Global Nerve Repair and Regeneration Market is accounted for $6.87 billion in 2021 and is expected to reach $14.36 billion by 2028 growing at a CAGR of 11.1% during the forecast period. Nerve repair and regeneration deals with the regrowth of nervous tissues, neurons, glial cells, myelin, synapses, axons and cell products. The mechanism for this process includes generation of new neurons, synapses, axons, glia and myelin. The complex, delicate structures that make up the nervous system-the brain, spinal cord, and peripheral nerves-are susceptible to various types of injury ranging from trauma to neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, and multiple system atrophy.

Market Dynamics:

Driver:

Increasing geriatric population

There has been an increased geriatric population around the developed regions of the world. The geriatric population is at a higher risk of neurologic disorders such as stroke, neuropathy, Alzheimer's disease, and Parkinson's disease. Their higher susceptibility makes geriatrics a key segment of the overall patient pool. As a result, the growth of this population segment will ensure a continued, intensified demand for nerve repair and regeneration for the treatment of neurological disorders.

Restraint:

High cost of neurostimulation and neuromodulation devices

There is a significant upfront cost for the use of neuromodulation devices. The high cost of these devices may lead to disproportionate application in geographical regions with different levels of financial resources. While neurostimulation serves as an expensive up-front cost for patients and insurance companies, costs to the nation's healthcare system, stemming from long-term issues with the treatment, are negligible. Moreover, the insurance companies cover costs for some therapies but not all. This affects the hospitals overall budget. Thus, this factor would play a significant role in hindering this market.

Opportunity:

Developing nations around the world

Developing countries such as India, China, and Brazil are expected to offer potential growth opportunities for market players during the forecast period. The huge population base, especially in India and China, is expected to be a major draw for companies in this market. This is bolstered by the rising incidence of neurological diseases like Alzheimer's, Parkinson's, and epilepsy. According to the World Bank, healthcare expenditure is increasing in these countries, supporting the growth of hospitals and ambulatory surgical centers in these countries. This is considered as a positive indicator for the market growth, as hospitals and ambulatory surgical centers are major end users of nerve repair and regeneration products.

Threat:

Uncertain clinical outcomes

Despite substantially increased understanding of neuropatho physiology and experimental evidence of promising neurotherapies, obtaining satisfactory clinical outcomes are challenging in cases of avulsion, crush or blast injuries of peripheral nerves. Although active rehabilitation following nerve injury may minimize the risk of disuse atrophy in muscle following nerve transaction or trauma, denervation atrophy of muscle targets is a major hurdle to nerve regeneration strategies. Even the best neuroregeneration, outcomes may be compromised due to the lack of a viable neuromuscular junction (NMJ) or muscle target leading to poor functional results.

The neurostimulation and neuromodulation devices segment is expected to be the largest during the forecast period

The neurostimulation and neuromodulation devices segment is driven by the increasing incidence of peripheral nerve injuries, technological development in the field, rising government expenditure for neurologic disorders, and favorable reimbursement. A large number of commercially available spinal cord products, investments by key companies to develop more effective devices and a wide range of applications were the factors responsible for the growth of the segment.

The hospitals segment is expected to have the highest CAGR during the forecast period

The increasing incidence of neurological disorders, the rising number of hospitals in emerging countries, and the growth and development of neuroepidemiology have been key driving factors boosting the growth of the hospital segment. Continuous monitoring is a valuable tool that helps by providing additional information to the medical and nursing staff about the physiologic condition of the patient. For instance, the Nicolet EEG Wireless Amplifier consolidates many clinical and research features into a single, portable unit for diagnosis and treatment of epilepsy, brain trauma, stroke, brain tumours, sleep dysfunction and clinical research. With the introduction of the new wireless amplifier, hospitals have a new standard of care available to them for diagnosing; monitoring and helping them treat patients with neurological disorders. This is considered as a positive indicator for the market growth, as hospitals are the major end-user of nerve repair and regeneration products.

Region with largest share:

North America is projected to hold the largest market share owing to the rising incidence of neurological disorders, favorable reimbursement policies, and the strong presence of industry players in this region. There is also the availability of technologically advanced devices that is a major factor for the dominance of this region. For instance, according to the Alzheimer's Association, number of Americans living with Alzheimer's is growing and growing fast. Moreover, the increasing government initiatives and funding and increased cases of neurological disorders, such as dementia, Alzheimer's disease and Parkinson's disease are also some of the major reasons responsible for the region's growth.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR due to the rising awareness among patients, supportive government initiatives, presence of unmet medical needs, and advent of innovative technologies. Economic growth in the countries of this region, rising prevalence of neurologic diseases, rising standard of living, growing demand for quality medical care, and increasing healthcare spending will drive the market in the region over the forecast period. China, India, Japan, Australia, and Singapore are the major countries contributing to the region's growth.

Key players in the market

Some of the key players profiled in the Nerve Repair and Regeneration Market include Abbott Laboratories, Medtronic, Plc. , Synapse Biomedical, Inc., Baxter International, Inc., Boston Scientific Corporation , Aleva Neurotherapeutics, Neuropace, Inc., Axogen, Inc., Collagen Matrix, Inc., Integra Lifesciences, Livanova, Plc., Kerimedical, Soterix Medical, Inc., Nevro Corp., and Polyganics .

Key developments:

In February 2020: LivaNova entered into partnership with Verily (US) for evaluation of the effectiveness of Vagus Nerve Stimulation Therapy (VNS Therapy) for difficult-to-treat Depression (DTD). LivaNova and Verily aim to gather quantitative data on patient behavior using technology and analytics developed by Verily to further understand depressive episodes and a patient's response to treatment.

In January 2020: Medtronic received CE approval for InterStim Micro neurostimulator and InterStim SureScan MRI leads, clearing the technologies for commercial sale and clinical use in Europe. The availability of the new technologies on January 15 will expand access to sacral neuromodulation (SNM) therapy for thousands of potential European patients by offering full-body MRI scan eligible, lifestyle-friendly choices with either the InterStim Micro or InterStim II neurostimulators.

In August 2019: Boston Scientific Corporation announced the U.S. Food and Drug Administration (FDA) approval of its ImageReady™ MRI labeling for the Vercise Gevia™ Deep Brain Stimulation (DBS) System to be used in a full-body magnetic resonance imaging (MRI) environment. This system, with the Vercise Cartesia™ Directional Lead, is designed to treat the symptoms of Parkinson's Disease (PD) by delivering precisely targeted electrical stimulation in the brain to provide optimal symptom relief and better control of unwanted side effects.

Products Covered:

  • Neurostimulation and Neuromodulation Devices
  • Biomaterials

Applications Covered:

  • Direct Nerve Repair/Neurorrhaphy
  • Stem Cell Therapy
  • Neurostimulation and Neuromodulation Surgeries
  • Nerve Grafting

End Users Covered:

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Nerve Repair and Regeneration Market, By Product

  • 5.1 Introduction
  • 5.2 Neurostimulation and Neuromodulation Devices
    • 5.2.1 External Neurostimulation Devices
      • 5.2.1.1 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
      • 5.2.1.2 Transcranial Magnetic Stimulation (TMS) Devices
      • 5.2.1.3 Respiratory electric stimulation (RES) devices
    • 5.2.2 Internal Neurostimulation Devices
      • 5.2.2.1 Spinal Cord Stimulation (SCS)
      • 5.2.2.2 Vagus Nerve Stimulation (VNS)
      • 5.2.2.3 Deep Brain Stimulation (DBS)
      • 5.2.2.4 Sacral Nerve Stimulation (SNS)
      • 5.2.2.5 Gastric Electrical Stimulation (GES)
  • 5.3 Biomaterials
    • 5.3.1 Nerve Protectors
    • 5.3.2 Nerve Connectors
    • 5.3.3 Nerve Wraps
    • 5.3.4 Nerve Conduits

6 Global Nerve Repair and Regeneration Market, By Application

  • 6.1 Introduction
  • 6.2 Direct Nerve Repair/Neurorrhaphy
    • 6.2.1 Perineural Repair
    • 6.2.2 Epineural Repair
    • 6.2.3 Group Fascicular Repair
  • 6.3 Stem Cell Therapy
  • 6.4 Neurostimulation and Neuromodulation Surgeries
    • 6.4.1 External Neurostimulation and Neuromodulation Surgeries
    • 6.4.2 Internal Neurostimulation and Neuromodulation Surgeries
  • 6.5 Nerve Grafting
    • 6.5.1 Allografts
    • 6.5.2 Autografts
    • 6.5.3 Xenografts

7 Global Nerve Repair and Regeneration Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.4 Ambulatory Surgery Centers

8 Global Nerve Repair and Regeneration Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 Medtronic, Plc.
  • 10.3 Synapse Biomedical, Inc.
  • 10.4 Baxter International, Inc.
  • 10.5 Boston Scientific Corporation
  • 10.6 Aleva Neurotherapeutics
  • 10.7 Neuropace, Inc.
  • 10.8 Axogen, Inc.
  • 10.9 Collagen Matrix, Inc.
  • 10.10 Integra Lifesciences
  • 10.11 Livanova, Plc.
  • 10.12 Kerimedical
  • 10.13 Soterix Medical, Inc.
  • 10.14 Nevro Corp.
  • 10.15 Polyganics

List of Tables

  • Table 1 Global Nerve Repair and Regeneration Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Nerve Repair and Regeneration Market Outlook, By Product (2020-2028) ($MN)
  • Table 3 Global Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Devices (2020-2028) ($MN)
  • Table 4 Global Nerve Repair and Regeneration Market Outlook, By External Neurostimulation Devices (2020-2028) ($MN)
  • Table 5 Global Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation Devices (2020-2028) ($MN)
  • Table 6 Global Nerve Repair and Regeneration Market Outlook, By Biomaterials (2020-2028) ($MN)
  • Table 7 Global Nerve Repair and Regeneration Market Outlook, By Nerve Protectors (2020-2028) ($MN)
  • Table 8 Global Nerve Repair and Regeneration Market Outlook, By Nerve Connectors (2020-2028) ($MN)
  • Table 9 Global Nerve Repair and Regeneration Market Outlook, By Nerve Wraps (2020-2028) ($MN)
  • Table 10 Global Nerve Repair and Regeneration Market Outlook, By Nerve Conduits (2020-2028) ($MN)
  • Table 11 Global Nerve Repair and Regeneration Market Outlook, By Application (2020-2028) ($MN)
  • Table 12 Global Nerve Repair and Regeneration Market Outlook, By Direct Nerve Repair/Neurorrhaphy (2020-2028) ($MN)
  • Table 13 Global Nerve Repair and Regeneration Market Outlook, By Perineural Repair (2020-2028) ($MN)
  • Table 14 Global Nerve Repair and Regeneration Market Outlook, By Epineural Repair (2020-2028) ($MN)
  • Table 15 Global Nerve Repair and Regeneration Market Outlook, By Group Fascicular Repair (2020-2028) ($MN)
  • Table 16 Global Nerve Repair and Regeneration Market Outlook, By Stem Cell Therapy (2020-2028) ($MN)
  • Table 17 Global Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 18 Global Nerve Repair and Regeneration Market Outlook, By External Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 19 Global Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 20 Global Nerve Repair and Regeneration Market Outlook, By Nerve Grafting (2020-2028) ($MN)
  • Table 21 Global Nerve Repair and Regeneration Market Outlook, By Allografts (2020-2028) ($MN)
  • Table 22 Global Nerve Repair and Regeneration Market Outlook, By Autografts (2020-2028) ($MN)
  • Table 23 Global Nerve Repair and Regeneration Market Outlook, By Xenografts (2020-2028) ($MN)
  • Table 24 Global Nerve Repair and Regeneration Market Outlook, By End User (2020-2028) ($MN)
  • Table 25 Global Nerve Repair and Regeneration Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 26 Global Nerve Repair and Regeneration Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 27 Global Nerve Repair and Regeneration Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)
  • Table 28 North America Nerve Repair and Regeneration Market Outlook, By Country (2020-2028) ($MN)
  • Table 29 North America Nerve Repair and Regeneration Market Outlook, By Product (2020-2028) ($MN)
  • Table 30 North America Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Devices (2020-2028) ($MN)
  • Table 31 North America Nerve Repair and Regeneration Market Outlook, By External Neurostimulation Devices (2020-2028) ($MN)
  • Table 32 North America Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation Devices (2020-2028) ($MN)
  • Table 33 North America Nerve Repair and Regeneration Market Outlook, By Biomaterials (2020-2028) ($MN)
  • Table 34 North America Nerve Repair and Regeneration Market Outlook, By Nerve Protectors (2020-2028) ($MN)
  • Table 35 North America Nerve Repair and Regeneration Market Outlook, By Nerve Connectors (2020-2028) ($MN)
  • Table 36 North America Nerve Repair and Regeneration Market Outlook, By Nerve Wraps (2020-2028) ($MN)
  • Table 37 North America Nerve Repair and Regeneration Market Outlook, By Nerve Conduits (2020-2028) ($MN)
  • Table 38 North America Nerve Repair and Regeneration Market Outlook, By Application (2020-2028) ($MN)
  • Table 39 North America Nerve Repair and Regeneration Market Outlook, By Direct Nerve Repair/Neurorrhaphy (2020-2028) ($MN)
  • Table 40 North America Nerve Repair and Regeneration Market Outlook, By Perineural Repair (2020-2028) ($MN)
  • Table 41 North America Nerve Repair and Regeneration Market Outlook, By Epineural Repair (2020-2028) ($MN)
  • Table 42 North America Nerve Repair and Regeneration Market Outlook, By Group Fascicular Repair (2020-2028) ($MN)
  • Table 43 North America Nerve Repair and Regeneration Market Outlook, By Stem Cell Therapy (2020-2028) ($MN)
  • Table 44 North America Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 45 North America Nerve Repair and Regeneration Market Outlook, By External Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 46 North America Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 47 North America Nerve Repair and Regeneration Market Outlook, By Nerve Grafting (2020-2028) ($MN)
  • Table 48 North America Nerve Repair and Regeneration Market Outlook, By Allografts (2020-2028) ($MN)
  • Table 49 North America Nerve Repair and Regeneration Market Outlook, By Autografts (2020-2028) ($MN)
  • Table 50 North America Nerve Repair and Regeneration Market Outlook, By Xenografts (2020-2028) ($MN)
  • Table 51 North America Nerve Repair and Regeneration Market Outlook, By End User (2020-2028) ($MN)
  • Table 52 North America Nerve Repair and Regeneration Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 53 North America Nerve Repair and Regeneration Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 54 North America Nerve Repair and Regeneration Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)
  • Table 55 Europe Nerve Repair and Regeneration Market Outlook, By Country (2020-2028) ($MN)
  • Table 56 Europe Nerve Repair and Regeneration Market Outlook, By Product (2020-2028) ($MN)
  • Table 57 Europe Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Devices (2020-2028) ($MN)
  • Table 58 Europe Nerve Repair and Regeneration Market Outlook, By External Neurostimulation Devices (2020-2028) ($MN)
  • Table 59 Europe Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation Devices (2020-2028) ($MN)
  • Table 60 Europe Nerve Repair and Regeneration Market Outlook, By Biomaterials (2020-2028) ($MN)
  • Table 61 Europe Nerve Repair and Regeneration Market Outlook, By Nerve Protectors (2020-2028) ($MN)
  • Table 62 Europe Nerve Repair and Regeneration Market Outlook, By Nerve Connectors (2020-2028) ($MN)
  • Table 63 Europe Nerve Repair and Regeneration Market Outlook, By Nerve Wraps (2020-2028) ($MN)
  • Table 64 Europe Nerve Repair and Regeneration Market Outlook, By Nerve Conduits (2020-2028) ($MN)
  • Table 65 Europe Nerve Repair and Regeneration Market Outlook, By Application (2020-2028) ($MN)
  • Table 66 Europe Nerve Repair and Regeneration Market Outlook, By Direct Nerve Repair/Neurorrhaphy (2020-2028) ($MN)
  • Table 67 Europe Nerve Repair and Regeneration Market Outlook, By Perineural Repair (2020-2028) ($MN)
  • Table 68 Europe Nerve Repair and Regeneration Market Outlook, By Epineural Repair (2020-2028) ($MN)
  • Table 69 Europe Nerve Repair and Regeneration Market Outlook, By Group Fascicular Repair (2020-2028) ($MN)
  • Table 70 Europe Nerve Repair and Regeneration Market Outlook, By Stem Cell Therapy (2020-2028) ($MN)
  • Table 71 Europe Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 72 Europe Nerve Repair and Regeneration Market Outlook, By External Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 73 Europe Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 74 Europe Nerve Repair and Regeneration Market Outlook, By Nerve Grafting (2020-2028) ($MN)
  • Table 75 Europe Nerve Repair and Regeneration Market Outlook, By Allografts (2020-2028) ($MN)
  • Table 76 Europe Nerve Repair and Regeneration Market Outlook, By Autografts (2020-2028) ($MN)
  • Table 77 Europe Nerve Repair and Regeneration Market Outlook, By Xenografts (2020-2028) ($MN)
  • Table 78 Europe Nerve Repair and Regeneration Market Outlook, By End User (2020-2028) ($MN)
  • Table 79 Europe Nerve Repair and Regeneration Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 80 Europe Nerve Repair and Regeneration Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 81 Europe Nerve Repair and Regeneration Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)
  • Table 82 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Country (2020-2028) ($MN)
  • Table 83 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Product (2020-2028) ($MN)
  • Table 84 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Devices (2020-2028) ($MN)
  • Table 85 Asia Pacific Nerve Repair and Regeneration Market Outlook, By External Neurostimulation Devices (2020-2028) ($MN)
  • Table 86 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation Devices (2020-2028) ($MN)
  • Table 87 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Biomaterials (2020-2028) ($MN)
  • Table 88 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Nerve Protectors (2020-2028) ($MN)
  • Table 89 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Nerve Connectors (2020-2028) ($MN)
  • Table 90 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Nerve Wraps (2020-2028) ($MN)
  • Table 91 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Nerve Conduits (2020-2028) ($MN)
  • Table 92 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Application (2020-2028) ($MN)
  • Table 93 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Direct Nerve Repair/Neurorrhaphy (2020-2028) ($MN)
  • Table 94 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Perineural Repair (2020-2028) ($MN)
  • Table 95 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Epineural Repair (2020-2028) ($MN)
  • Table 96 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Group Fascicular Repair (2020-2028) ($MN)
  • Table 97 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Stem Cell Therapy (2020-2028) ($MN)
  • Table 98 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 99 Asia Pacific Nerve Repair and Regeneration Market Outlook, By External Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 100 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 101 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Nerve Grafting (2020-2028) ($MN)
  • Table 102 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Allografts (2020-2028) ($MN)
  • Table 103 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Autografts (2020-2028) ($MN)
  • Table 104 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Xenografts (2020-2028) ($MN)
  • Table 105 Asia Pacific Nerve Repair and Regeneration Market Outlook, By End User (2020-2028) ($MN)
  • Table 106 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 107 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 108 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)
  • Table 109 South America Nerve Repair and Regeneration Market Outlook, By Country (2020-2028) ($MN)
  • Table 110 South America Nerve Repair and Regeneration Market Outlook, By Product (2020-2028) ($MN)
  • Table 111 South America Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Devices (2020-2028) ($MN)
  • Table 112 South America Nerve Repair and Regeneration Market Outlook, By External Neurostimulation Devices (2020-2028) ($MN)
  • Table 113 South America Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation Devices (2020-2028) ($MN)
  • Table 114 South America Nerve Repair and Regeneration Market Outlook, By Biomaterials (2020-2028) ($MN)
  • Table 115 South America Nerve Repair and Regeneration Market Outlook, By Nerve Protectors (2020-2028) ($MN)
  • Table 116 South America Nerve Repair and Regeneration Market Outlook, By Nerve Connectors (2020-2028) ($MN)
  • Table 117 South America Nerve Repair and Regeneration Market Outlook, By Nerve Wraps (2020-2028) ($MN)
  • Table 118 South America Nerve Repair and Regeneration Market Outlook, By Nerve Conduits (2020-2028) ($MN)
  • Table 119 South America Nerve Repair and Regeneration Market Outlook, By Application (2020-2028) ($MN)
  • Table 120 South America Nerve Repair and Regeneration Market Outlook, By Direct Nerve Repair/Neurorrhaphy (2020-2028) ($MN)
  • Table 121 South America Nerve Repair and Regeneration Market Outlook, By Perineural Repair (2020-2028) ($MN)
  • Table 122 South America Nerve Repair and Regeneration Market Outlook, By Epineural Repair (2020-2028) ($MN)
  • Table 123 South America Nerve Repair and Regeneration Market Outlook, By Group Fascicular Repair (2020-2028) ($MN)
  • Table 124 South America Nerve Repair and Regeneration Market Outlook, By Stem Cell Therapy (2020-2028) ($MN)
  • Table 125 South America Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 126 South America Nerve Repair and Regeneration Market Outlook, By External Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 127 South America Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 128 South America Nerve Repair and Regeneration Market Outlook, By Nerve Grafting (2020-2028) ($MN)
  • Table 129 South America Nerve Repair and Regeneration Market Outlook, By Allografts (2020-2028) ($MN)
  • Table 130 South America Nerve Repair and Regeneration Market Outlook, By Autografts (2020-2028) ($MN)
  • Table 131 South America Nerve Repair and Regeneration Market Outlook, By Xenografts (2020-2028) ($MN)
  • Table 132 South America Nerve Repair and Regeneration Market Outlook, By End User (2020-2028) ($MN)
  • Table 133 South America Nerve Repair and Regeneration Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 134 South America Nerve Repair and Regeneration Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 135 South America Nerve Repair and Regeneration Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)
  • Table 136 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Country (2020-2028) ($MN)
  • Table 137 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Product (2020-2028) ($MN)
  • Table 138 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Devices (2020-2028) ($MN)
  • Table 139 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By External Neurostimulation Devices (2020-2028) ($MN)
  • Table 140 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation Devices (2020-2028) ($MN)
  • Table 141 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Biomaterials (2020-2028) ($MN)
  • Table 142 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Nerve Protectors (2020-2028) ($MN)
  • Table 143 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Nerve Connectors (2020-2028) ($MN)
  • Table 144 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Nerve Wraps (2020-2028) ($MN)
  • Table 145 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Nerve Conduits (2020-2028) ($MN)
  • Table 146 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Application (2020-2028) ($MN)
  • Table 147 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Direct Nerve Repair/Neurorrhaphy (2020-2028) ($MN)
  • Table 148 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Perineural Repair (2020-2028) ($MN)
  • Table 149 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Epineural Repair (2020-2028) ($MN)
  • Table 150 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Group Fascicular Repair (2020-2028) ($MN)
  • Table 151 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Stem Cell Therapy (2020-2028) ($MN)
  • Table 152 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 153 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By External Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 154 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
  • Table 155 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Nerve Grafting (2020-2028) ($MN)
  • Table 156 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Allografts (2020-2028) ($MN)
  • Table 157 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Autografts (2020-2028) ($MN)
  • Table 158 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Xenografts (2020-2028) ($MN)
  • Table 159 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By End User (2020-2028) ($MN)
  • Table 160 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 161 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 162 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)